Arrowhead Pharmaceuticals
Pasadena · Founded 1989
About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Company Facts
- Founded: 1989
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $500K – $1M
- Total funding: $2.4B
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:ARWR
- Website: arrowheadpharma.com
- Phone: (626) 304-3400
Industries & Categories
Biotechnology, Health Care, Nanotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/arrowhead-pharmaceuticals-102132 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.